Neurofeedback Treatment of Chronic Inpatient Schizophrenia

Auteurs-es

  • Angelo S. Bolea

DOI :

https://doi.org/10.1080/10874200903543971

Résumé

This is a study on the effect of neurofeedback on chronic inpatient complex
paranoid schizophrenics. The purpose of this research was twofold: first, to determine the effects of the application of neurofeedback to very chronic cases of schizophrenia that had been resistant to years of inpatient medical and psychological treatment and second, to propose a connection paradigm of schizophrenia. The author obtained progress using neurofeedback with more than 70 hospital inpatients with chronic schizophrenia. Improvements were seen in the EEG patterns and in cognitive, affective and behavioral patterns that often resulted in successful release from the hospital to live in the community. A 2-year follow up found that positive changes were sustained. It is the author’s impression that reinforcement of right parietal alpha and inhibiting frontal delta and fast beta activity obtained the best results.

Téléchargements

Publié-e

2010-02-26

Numéro

Vol. 14 No. 1 (2010)

Rubrique

CLINICAL CORNER

Licence

© International Society for Neurofeedback and Research (ISNR), all rights reserved. This article (the “Article”) may be accessed online from ISNR at no charge. The Article may be viewed online, stored in electronic or physical form, or archived for research, teaching, and private study purposes. The Article may be archived in public libraries or university libraries at the direction of said public library or university library. Any other reproduction of the Article for redistribution, sale, resale, loan, sublicensing, systematic supply, or other distribution, including both physical and electronic reproduction for such purposes, is expressly forbidden. Preparing or reproducing derivative works of this article is expressly forbidden. ISNR makes no representation or warranty as to the accuracy or completeness of any content in the Article.  From 1995 to 2013 the Journal of Neurotherapy was the official publication of ISNR (www. Isnr.org); on April 27, 2016 ISNR acquired the journal from Taylor & Francis Group, LLC. In 2014, ISNR established its official open-access journal NeuroRegulation (ISSN: 2373-0587; www.neuroregulation.org).